Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06561633
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-16
Brief Title:
The Influence Factors of Bispectral Index Values Increment Caused by Sugammadex
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Influence Factors of Bispectral Index Values Increment Caused by Sugammadex Administration During Steady-state Anesthesia
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Sugammadex administration may increase the bispectral index BIS values during general anesthesia The purpose of this study was to investigate the influence factors leading to increase in BIS value caused by sugammadex administration when continuous use of general anesthetics
Detailed Description:
Sugammadex administration may increase the bispectral index BIS values during general anesthesia The purpose of this study was to investigate the influence factors leading to increase in BIS value caused by sugammadex administration when continuous use of general anesthetics Patients undergoing elective surgery were included in this study After surgery was completed while the train-of-four ratio was zero a steady-state intravenous anesthesia was maintained to keep a BIS value within the range of 40-60 for at least 5 minutes Patients received sugammadex 2 mgkg-1 after completed surgery BIS values were recorded every minute and clinical signs of awaking was also noted
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None